Targeted Diagnostics CoreMap develops patient-specific diagnostic technology for electrophysiologists addressing atrial fibrillation, presenting a sales opportunity for specialized imaging and monitoring solutions that can be bundled with personalized treatment planning tools.

Growth Capital Recent financing rounds totaling at least 23 million indicate investor confidence and momentum, suggesting readiness for commercial scale, pilot deployments, and expanded clinical studies that sales teams can leverage to secure pilots with aligned hospital networks.

Regulatory Readiness ISO 13485 certification cited in tech stack demonstrates strong quality management for medical devices, enabling smoother procurement cycles and faster market access discussions with hospitals and EMR-integrated deployments.

Regional Focus Based in Burlington, MA with a smaller employee base signals a potential partner for regional pilots and pilot sites on the East Coast, offering a focused territory to establish case studies and reference sites.

Strategic Partnerships Notable investor interest from MassMEDIC and Qure Ventures suggests a network through which CoreMap can access academic centers, cardiology departments, and early adopters, facilitating introductions and co-development opportunities.